Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
상품코드:1726418
리서치사:Kalorama Information
발행일:2025년 05월
페이지 정보:영문 685 Pages
라이선스 & 가격 (부가세 별도)
한글목차
이번에 제12판이 되는 「세계의 포인트 오브 케어(POC) 진단 검사 시장」은 시장을 세계의 시점으로부터 분석했으며, 5년간의 예측을 제공합니다.
세계의 포인트 오브 케어(POC) 진단 검사 시장 : 제12판은 세계의 POC 진단 검사 시장을 종합적으로 분석했으며, 2029년까지의 예측을 제공합니다. 기존의 실험실 베이스 분석장치가 체외진단(IVD) 업계의 중심이 되는 것은 아니지만, POC 분야는 다양한 건강 관리 환경에서 신속하고 사용하기 쉬운 검사 수요에 견인되어 역동적인 성장 분야로 부상하고 있습니다.
제12판이 되는 본 보고서에서는 20년에 걸쳐 POC의 동향을 추적해 온 전문 지식을 바탕으로 환자 케어의 강화, 임상적 의사결정 지원, 병원에서 가정으로의 분산형 검사의 실현 등 진화하는 진단 검사의 역할에 관한 상세한 인사이트를 제공합니다. 이 보고서는 스마트폰, 바이오 센서, 랩 칩 플랫폼 및 웨어러블 장치와 같은 기술 혁신이 POC 전망을 재구성하는 방법에 중점을 둡니다.
본 조사에서는 포도당, 심장 마커, 감염증, 중환자 치료 등의 주요 검사 카테고리를 상세하게 세분화하여 시장 규모, 성장 예측, 경쟁 분석을 제공합니다.
Now in its twelfth edition - Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast.
"Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition" provides a comprehensive analysis of the global POC diagnostics market, with forecasts extending through 2029. While traditional lab-based analyzers remain central to the in vitro diagnostics (IVD) industry, the POC segment has emerged as a dynamic growth area, driven by the demand for rapid, accessible testing across diverse healthcare settings.
This twelfth edition builds on Kalorama Information's two decades of expertise in tracking POC trends, offering detailed insights into the evolving role of diagnostics in enhancing patient care, supporting clinical decision-making, and enabling decentralized testing-from hospitals to homes. The report highlights how technological innovations such as smartphones, biosensors, lab-on-a-chip platforms, and wearable devices are reshaping the POC landscape.
The study features in-depth segmentation across key test categories-including glucose, cardiac markers, infectious diseases, and critical care-and provides market sizing, growth projections, and competitive analysis. It also examines the diverse venues where POC testing is performed, from emergency departments and retail clinics to nursing homes and self-testing environments.
Enhanced Segmentation - Many Reports in One
The report delves into various areas of POC diagnostics, including:
Blood and Electrolytes (including Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC)
Cancer Tumor Markers
Cardiac Markers
Coagulation
Colon Cancer
Drugs of Abuse
Fecal Occult Blood
Glucose (including CGM and Diabetes/HbA1c)
Infectious Disease (including C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others)
Lipid
Pregnancy/Fertility
Urine
Other Testing (including allergy, autoimmune, microbiology, TSH)
Each area is thoroughly analyzed, providing market sizing and forecasts.
Scope and Methodology
With global coverage spanning the U.S., Europe, Japan, and emerging markets, the report offers regional breakdowns and insights into regulatory trends, such as the pursuit of CLIA waivers and CE Marks. Data is based on extensive primary and secondary research, including interviews with over 35 industry stakeholders. Market estimates reflect manufacturer-level revenues, with forecasts from 2024 to 2029 and compound annual growth rates (CAGRs) for each segment.
WHO BENEFITS – DEFINITE TARGETS
Diagnostic and Medical Device Companies
Product managers, strategic planners, and business development leaders in companies that manufacture or distribute POC devices.
Teams looking to identify growth opportunities, track technology trends, and assess market sizing for new or existing product lines.
Investors and Private Equity Firms
Healthcare investors seeking data-backed insights into high-growth diagnostics segments.
Firms evaluating acquisition targets or considering entry into the POC diagnostics space.
POTENTIAL PAIN POINTS ADDRESSED
Uncertainty About Where the Market Is Growing
The report offers clear five-year forecasts by test type and region—helping users decide where to invest, launch, or expand.
Lack of Granular Market Data
With enhanced segmentation, the report addresses the need for detailed insights across test categories (e.g., glucose, colon cancer, HIV, etc.), replacing the need to purchase multiple niche reports.
Confusion About Competitive Landscape
Provides competitive analysis, helping companies understand who the key players are and where they are succeeding.
Need to Justify Business Decisions with Market Evidence
Market sizing, growth rates, and data-driven validation enable evidence-based planning for R&D, M&A, and product strategy.
Navigating Technological Shifts in Diagnostics
Identifies disruptive innovations such as smartphones, lab-on-a-chip, and wearable POC tools—guiding future product development and partnerships.
Regulatory Uncertainty
Tracks regulatory trends, helping teams assess approval hurdles and align development with market-access strategy.
Table of Contents
Chapter 1: Executive Summary
Introduction
Scope and Methodology
Size and Growth of the Market
Table 1-1: Global POC Test Market, 2024-2029 ($ million)
Figure 1-1: Global POC Test Market, 2024-2029 ($ million)
Trends Affecting the Market
Competitive Outlook
Sixteen Key Market Conclusions
Conclusion One - POC Market Transformed by Technological Progress
Conclusion Two - POC Molecular Diagnostics Continue Making Inroads
Conclusion Three - Prevention and Early Detection at the Core of POC Development
Conclusion Four - Wearables Continue to Influence POC Markets
Conclusion Five - Test Costs Will Remain a Global Challenge
Conclusion Six - Rising Demand Will Drive POC Growth in RoW Markets
Conclusion Seven - New Venues: Urgent & Retail Care
Conclusion Eight - COVID-19's Positive Effect
Conclusion Nine - New Opportunities in Infectious Disease POC Testing
Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2024-2029 ($ million)
Figure 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2024-2029 ($ million)
POC HbA1c Testing
Table 3-9: Global POC Glucose HbA1c Professional Testing Market, 2024-2029 ($ million)
Figure 3-9: Global POC Glucose HbA1c Professional Testing Market, 2024-2029 ($ million)
Competitive Analysis
Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
Figure 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
Figure 3-11: Global POC Glucose Test Manufacturer Shares, by Leading Suppliers, 2024 (%) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
Chapter 4: POC Blood and Electrolytes Testing Market
Types of Blood and Electrolytes Tests
Hemoglobin/Hematocrit
WBC and Other
Blood Gases
Electrolytes
Products
Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2024
Figure 6-2: POC Rapid Cardiac Markers Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
Competitive Analysis
Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 6-3: Global POC Cardiac Markers Test Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 6-4: Global POC Cardiac Markers Test Manufacturers, Market Share of Leading Suppliers, 2024 (%) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
Chapter 7: POC Substance Abuse
Overview
Products
Urine
Oral
Blood
Hair
Market Size and Growth
Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment, and criminal) Market Analysis, 2024-2029 ($ million)
Figure 7-1: Global POC Drugs of Abuse Testing (critical care, employment, and criminal) Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 7-2: POC Substance Abuse Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Drugs of Abuse Self-Testing
Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2024-2029 ($ million)
POC Drugs of Abuse Professional Testing
Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 7-3: Global POC Drugs of Abuse Market, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
Figure 7-4: Global POC Drugs of Abuse Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
Figure 7-5: Global POC Drug of Abuse Testing Manufacturer Market Share, by Leading Suppliers, 2024 (%) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
Chapter 8: POC Pregnancy and Fertility Testing
Products
Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer's Instrument / Device / Assay
Market Size and Growth
Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2024-2029 ($ million)
Figure 8-1: Global POC Pregnancy and Fertility Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 8-2: POC Pregnancy and Fertility Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 8-3: POC Pregnancy and Fertility Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [bioMerieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
Figure 8-4: Global POC Pregnancy and Fertility Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [bioMerieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
Figure 8-5: Global POC Pregnancy and Fertility Testing Manufacturer Share, by Leading Suppliers, 2024 (%) [bioMerieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing
Products
Table 9-1: Selected POC Colon Cancer Tests
Market Size and Growth
Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2024-2029 ($ million)
Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 9-2: POC Colon Cancer Screening/Fecal Occult Blood Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
Figure 10-3: POC Infectious Disease Testing (including COVID-19) Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
POC Infectious Disease Testing by Disease Type
Table 10-7: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2024 ($ million) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
Figure 10-4: Global POC Infectious Disease Revenues, by Disease Type, 2024 ($ million) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
Figure 10-5: Global POC Infectious Disease, Percent of Infectious Disease Market by Disease Type, 2024 (%) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
Competitive Analysis
Table 10-8: Global POC Infectious Disease (including COVID-19) Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 10-6: Global POC Infectious Disease (including COVID-19) Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 10-7: Global POC Infectious Disease (including COVID-19) Testing Manufacturers, Market Share of Leading Suppliers, 2024 (%) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
Table 12-2: Global POC Cancer Testing Market Analysis, 2024-2029 ($ million)
Figure 12-1: Global POC Cancer Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 12-2: POC Cancer Tumor Marker Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
Competitive Analysis
Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Beckman Coulter, bioMerieux, QuidelOrtho, Others]
Figure 12-3: Global POC Cancer Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Beckman Coulter, bioMerieux, QuidelOrtho, Others]
Figure 12-4: Global POC Cancer Testing Manufacturers Share, by Leading Suppliers, 2024 (%) [Beckman Coulter, bioMerieux, QuidelOrtho, Others]
Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 ($ million) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
Figure 16-6: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 ($ million) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
Figure 16-7: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 (%) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
Market Analysis by Country
Table 16-5: Global POC Testing Analysis, by Region/Country, 2024 ($ million) [Europe, Japan, United States, Rest of World]
Figure 16-8: Global POC Testing Analysis, by Region/Country, 2024 ($ million) [Europe, Japan, United States, Rest of World]
Figure 16-9: Global POC Testing Market Analysis, Share by Region/Country, 2024 (%) [Europe, Japan, United States, Rest of World]
United States
Table 16-6: United States POC Testing Market Analysis, 2024-2029 ($ million)
Europe
Table 16-7: Europe POC Testing Market Analysis, 2024-2029 ($ million)
Germany
France
UK
Switzerland and Sweden
Russia and Other Europe
Figure 16-10: Europe POC Testing Participation, Share of European Market by Country, 2024 (%) [France, Germany, Italy, Spain, Switzerland/Norway, United Kingdom, Others]
Japan
Table 16-8: Japan POC Testing Market Analysis, 2024-2029 ($ million)
Rest of World
Latin America
China
India
South Korea
Other Rest of World Countries
Table 16-9: Global POC Testing Market Analysis, by Rest of World Region/Country, 2024 ($ million) [Australia, Canada, China, India, Latin America, the Middle East, South Korea and other Asian countries, Other]
Figure 16-11: Global POC Testing Market Analysis, Share of Rest of World by Region/Country, 2024 (%) [Australia, China, India, Latin America, South Korea, Other]
Competitive Analysis
Table 16-10: Global Top 10 POC Testing Market Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 16-12: Global Top 10 POC Testing Market Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 16-13: Global POC Testing Market Share by Leading Suppliers, 2024 (%) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
